Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lineage Cell Therapeutics (LCTX) Debt Ratio: 2014-2021

Historic Debt Ratio for Lineage Cell Therapeutics (LCTX) over the last 5 years, with Mar 2021 value amounting to 0.00.

  • Lineage Cell Therapeutics' Debt Ratio was N/A to 0.00 in Q1 2021 from the same period last year, while for Mar 2021 it was 0.00, marking a year-over-year change of. This contributed to the annual value of 0.00 for FY2020, which is N/A change from last year.
  • As of Q1 2021, Lineage Cell Therapeutics' Debt Ratio stood at 0.00, which was down 15.62% from 0.00 recorded in Q4 2020.
  • In the past 5 years, Lineage Cell Therapeutics' Debt Ratio ranged from a high of 0.01 in Q3 2020 and a low of 0.00 during Q4 2017.
  • Its 2-year average for Debt Ratio is 0.00, with a median of 0.00 in 2020.
  • Data for Lineage Cell Therapeutics' Debt Ratio shows a maximum YoY slumped of 87.66% (in 2017) over the last 5 years.
  • Lineage Cell Therapeutics' Debt Ratio (Quarterly) stood at 0.00 in 2017, then followed by 0.00 in 2020, then followed by 0.00 in 2021.
  • Its last three reported values are 0.00 in Q1 2021, 0.00 for Q4 2020, and 0.01 during Q3 2020.